About New Health Sciences, Inc.
New Health Sciences, Inc. is developing and commercializing two, strategically linked technologies.
Hemodyanamic Vascular Analysis (HVA) is a safe, precise and inexpensive method for diagnosing and managing neurovascular disease. HVA is the only quantitative, sensitive, reproducible physiological means of measuring and describing changes in vascular function that signal the presence or risk of cerebral vascular disease.
Hemanext, is a novel technology that delivers red blood cells (RBCs) of higher efficacy for transfusion therapy, and at the same time, extends the shelf life of refrigerated RBCs.